The Skyhawk name, which was chosen and announced at the end of the 2023-24 school year, pays tribute to Oriskany’s ...

Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous PolyposisUnderscores unmet need for a ...

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...

Everyone's favorite killer AI companion is back with some modifications in the 'M3GAN 2.0' trailer, which debuted during Sunday's Super Bowl LIX.

As we grieve our losses, I’m comforted and humbled to know that the persecuted church is interceding on our behalf.

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on new products for rare diseases, today announced positive top-line results from ...

Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...

The "Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Training Course" conference has been added to ResearchAndMarkets.com's offering. The Common ...

Previously dubbed Orphan, the series is inspired by the true story of Natalia Grace and the Midwestern couple who adopted her believing she was a little girl with dwarfism but gradually started to ...

(GAZA CITY) -- Alma Ja'arour is not like most children her age. Instead of talking about school and friends, her days are filled with memories of the family she lost and the uncertainty of her ...

Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced that it will share real-world data about ...